Prostate cancer
Conditions
Interventions
Sponsors
Shanghai Changhai Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Men aged more than 18 years. 2. Men with a diagnosis of prostate adenocarcinoma confirmed by biopsy results. 3. Gleason score was 8-9 points. 4. Men with an expected survival exceeding 5 years. 5. ECOG 0-1 6. The participant is well-informed of the current treatment options and the design of this trial; he/she is willing and able to give informed consent for participation in the study.
Exclusion criteria
Exclusion criteria: A patient may not enter the study if ANY of the following applies: 1. Bone metastasis or distant organ metastasis; 2. Prior exposure to any treatment for prostate cancer, including radiotherapy, chemotherapy, hormone therapy, focal therapy, etc.; 3. Prior transurethral enucleation or resection of the prostate; 4. Any abdominal surgery performed within 3 months prior to enrollment; 5. A transrectal prostate biopsy performed within 2 weeks prior to enrollment; 6. Sustained use of anticoagulation and antiplatelet drugs; 7. Any other previous or current malignancies; 8. Disease complicated by other severe systemic diseases which, in the judgment of the investigators, are likely to interfere with the treatment, assessment or compliance associated with this trial; 9. Participation in other trials which are ongoing or have been completed within 3 months; 10. Any contraindications for radiation therapy or surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Imaging report information; | — |
Secondary
| Measure | Time frame |
|---|---|
| prostate specific antigen (PSA) level;rates of positive surgical margin; | — |
Countries
China
Contacts
Public ContactShancheng Ren
Department of Urology, Shanghai Changhai Hospital
Outcome results
None listed